AZD-4144

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameAZD-4144
Drug Alias NameAZD4144AZD-4144AZ-0065
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsKidney Failure, ChronicAcute Kidney InjuryRenal Insufficiency +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[15] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsKidney Failure, ChronicAcute Kidney InjuryRenal Insufficiency +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A